Compass Therapeutics's total assets for Q3 2025 were $231.26M, an increase of 98.17% from the previous quarter. CMPX total liabilities were $21.65M for the fiscal quarter, a -7.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.